Bone Biologics Corp insider trading

Every open-market purchase and sale by Bone Biologics Corp's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

No open-market insider trades reported in the last five years.

Does following Bone Biologics Corp’s insiders pay?

From September 26, 2014 to January 17, 2020, 7 insiders reported 3 open-market purchases and 6 sales not made under a pre-set plan in Bone Biologics Corp.

Bone Biologics Corp: each insider's record
Insider	Role	Purchases	12 months after their purchases	Beat the S&P 500	Sales	12 months after their sales	Latest report
Afh Holding & Advisory, LLC	10% owner	0	—	—	2	—	December 2, 2015
Musculoskeletal Transplant Foundation, Inc.	10% owner	1	—	—	1	—	March 7, 2016
Don Hankey Trust	Chairman of the Board	1	—	—	0	—	January 17, 2020
Hankey Bret	Director	1	—	—	0	—	January 17, 2020
Heshmatpour Amir F	10% owner	0	—	—	1	—	October 19, 2015
Soo B Chia	Director	0	—	—	1	—	December 18, 2015
Wu Benjamin	Director	0	—	—	1	—	December 21, 2015

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

← Back to Bone Biologics Corp · Funds · Politicians